Atopic, contact, and the itch-scratch cycle.
Blistering in the elderly and hives that last for years now answer to the same eczema injection — which says something uncomfortable about how dermatology names things.
Hands have been treated with steroids and hope for decades. A topical pan-JAK inhibitor is the first drug approved specifically for the condition — and in a head-to-head it outperformed the oral alternative on both efficacy and side effects.
The fear of topical steroids is measurable, widespread, and mostly attached to a risk profile that ordinary use does not produce — while under-treatment quietly does its own damage.
Moderate eczema has quietly become one of the best-served conditions in medicine — and an enormous number of people are still cycling the same mid-potency tube they were handed years ago.
Irritant and allergic contact dermatitis can look identical on the arm and take opposite instructions — and the single most common mistake in skincare is applying the tolerance-building logic of one to the immune memory of the other.
Contact allergy has a very long tail and a very short head — and knowing what sits at the head of the distribution, plus the aliases it hides behind, solves more cases than most people's process of elimination ever will.
Read the list backwards and you get a history of the cosmetics industry replacing one preservative with another — and discovering, about a decade later, what it replaced it with.
POEM counts how often your symptoms showed up last week. ADCT asks whether the disease is beaten. Confusing the two is how treatment gets withdrawn from people whose eczema is still winning.
Sometimes it isn't sensitive skin or a harsh formula — it's a true immune allergy to one ingredient you use every day. Telling irritation from allergy is the whole game.
Atopic, nummular, dyshidrotic, contact: four distinct patterns hide under one word, each with its own triggers and its own fix. Naming yours is the first step that actually works.